Researchers reveal pathogenesis and therapeutic strategy of pre-engraftment syndrome
Severe PES is characterized by high fever, rash, diarrhea, and increased transplant-related mortality. A study revealed that monocytes derived from cord blood produce proinflammatory cytokines, leading to PES. Tocilizumab treatment significantly controlled clinical symptoms and reduced mortality in patients with severe PES